New hope for liver cancer patients suffering from wasting syndrome

This study looks at whether adding a special form of megestrol acetate to standard treatment can help improve appetite and body weight in people with advanced liver cancer who are experiencing cachexia (severe weight loss and muscle wasting). About 68 participants will be randomly assigned to receive either the drug combo or standard therapy alone. The goal is to see if the combination leads to better appetite and higher BMI during treatment.